SAMARITAN NEWSLETTER 08-13-2026

SAMARITAN PROJECTS LLC

4415 Gladstone Blvd.

Kansas City, MO 64123

SP@NorridLaw.com CorrLinks

Rusty 417 236 1179

Steve 816 562 4981

The SAMARITAN-PROJECT prepares post-conviction and compassionate release motions under the direction of Attorney Tom Norrid. The Project retrieves documents at reasonable prices. The Project newsletter reports every winning published district court and court of appeals case for the week in review.

United States v. Joseph Martino, Case No. 3:19-cr-03387 (S.D. Cal. — Aug. 6, 2026): Defendant suffers from Job’s syndrome (a primary immunodeficiency causing recurrent staphylococcal infections and impaired healing), chronic post‑surgical back pain limiting mobility and tolerance for prolonged sitting, and diagnoses including mild degenerative disc disease, cervical degenerative changes, sciatica, arthritis, and neuropathy (Amended Presentence Report, ECF No. 65, pp. 23–24). The court was aware of these conditions at sentencing and recommended designation to a medical facility to provide care and treatment. Time served.

United States v. Brummett, 2026 U.S. Dist. LEXIS 177229 (E.D. Tenn. — Aug. 7, 2026): Defendant’s motion for compassionate release was denied, but the motion for sentence reduction under Amendment 821 was granted. The court found that the amended guidelines range, together with the defendant’s post‑conviction conduct and consideration of the 18 U.S.C. § 3553(a) factors, warranted a reduced sentence. Sentence reduced to 121 months’ imprisonment.

United States v. Enriquez, 2026 U.S. Dist. LEXIS 166271 (S.D. Cal. — July 27, 2026): The court granted the defendant’s motion to reduce the sentence to time served, relying on the defendant’s current health conditions, age, and the relevant sentencing factors.

United States v. Hogsett, 2026 U.S. Dist. LEXIS 162845 (S.D. Ill. — July 22, 2026): The undisputed medical evidence showed the defendant was diagnosed with advanced-stage chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL), and an oncologist opined specialized care was required. The court found the diagnosis constituted “extraordinary and compelling reasons” under § 1B1.13(b)(1)(A) and granted compassionate release, reducing the sentence to time served; upon release the defendant will begin the previously imposed five‑year supervised release.

United States v. Rhymes, 2026 U.S. Dist. LEXIS 162789 (S.D.N.Y. — July 22, 2026): The opinion echoes findings that advanced CLL/SLL, supported by expert medical evidence, can satisfy the “extraordinary and compelling” threshold under § 1B1.13(b)(1)(A).

United States v. Gatling, 2026 U.S. Dist. LEXIS 164548 (D. Conn. — July 21, 2026): The court emphasized that the defendant had completed the imprisonment portion of his sentence, had been living successfully in a halfway house and working full‑time, and that his mother’s deteriorating medical condition following multiple strokes required a caregiver whom the defendant was prepared to provide. The court found the penological purposes of imprisonment largely served and granted release based on these circumstances.

United States v. Peterson, 2026 U.S. Dist. LEXIS 161851 (D.S.D. — July 20, 2026): The defendant, sentenced in February 2022 to the mandatory minimum 10 years for conspiracy to distribute a controlled substance and currently housed at FMC Carswell (projected release Aug. 14, 2029), sought compassionate release based on medical conditions. The United States agreed the defendant established “extraordinary and compelling reasons” for eligibility and left the § 3553(a) balancing to the court; the court ordered that the compassionate‑release motion be granted.